REV1: A novel biomarker and potential therapeutic target for various cancers

Overview of attention for article published in Frontiers in Genetics, September 2022

Altmetric Badge

About this Attention Score

Above-average Attention Score compared to outputs of the same age and source (56th percentile)

Mentioned by

twitter: 2 X users

Citations

dimensions_citation: 4 Dimensions

Readers on

mendeley: 11 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 2 X posts from 2 X users, with an upper bound of 6,489 followers.

New article: REV1: A novel biomarker and potential therapeutic target for various cancers https://t.co/JJkLl02wrR #AML #leusm #hematology https://t.co/hLY5wHu5nT

17 Oct 2022

Reply Repost Favourite

New Research: REV1: A novel biomarker and potential therapeutic target for various cancers: Background: REV1 is a member of the translesion synthesis DNA polymerase Y family. It is an essential player in a variety of DNA replication activities,… https://t.

30 Sep 2022

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.